Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.004x

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a cash flow conversion efficiency ratio of -0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.19 Million ≈ $-1.49 Million USD) by net assets (CN¥2.63 Billion ≈ $385.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Anhui Huaheng Biotechnology Co. Ltd. A to measure how much of total assets are equity-financed.

Anhui Huaheng Biotechnology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Anhui Huaheng Biotechnology Co. Ltd. A (688639) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Veken Elite SHG:600152	0.045x
Warteck Invest Ltd SW:WARN	0.021x
Sweetgreen Inc NYSE:SG	-0.004x
Wuhan Sanzhen Industry Holding Co Ltd SHG:600168	0.023x
Climb Bio Inc NASDAQ:CLYM	-0.097x
Heilongjiang Publishing & Media Co Ltd SHG:605577	0.034x
AMN Healthcare Services Inc NYSE:AMN	0.035x
Suzhou Xingye Material Tech SHG:603928	-0.006x

Annual Cash Flow Conversion Efficiency for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Anhui Huaheng Biotechnology Co. Ltd. A (688639) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.63 Billion ≈ $385.12 Million	CN¥104.55 Million ≈ $15.30 Million	0.040x	-49.13%
2024-12-31	CN¥2.56 Billion ≈ $374.37 Million	CN¥199.79 Million ≈ $29.24 Million	0.078x	-53.14%
2023-12-31	CN¥1.83 Billion ≈ $267.15 Million	CN¥304.28 Million ≈ $44.53 Million	0.167x	-30.91%
2022-12-31	CN¥1.48 Billion ≈ $216.81 Million	CN¥357.43 Million ≈ $52.30 Million	0.241x	+198.23%
2021-12-31	CN¥1.18 Billion ≈ $173.13 Million	CN¥95.70 Million ≈ $14.00 Million	0.081x	-63.84%
2020-12-31	CN¥489.78 Million ≈ $71.67 Million	CN¥109.57 Million ≈ $16.03 Million	0.224x	-54.55%
2019-12-31	CN¥368.68 Million ≈ $53.95 Million	CN¥181.48 Million ≈ $26.56 Million	0.492x	+71.02%
2018-12-31	CN¥310.29 Million ≈ $45.41 Million	CN¥89.31 Million ≈ $13.07 Million	0.288x	-42.61%
2017-12-31	CN¥210.73 Million ≈ $30.84 Million	CN¥105.69 Million ≈ $15.47 Million	0.502x	+60.67%
2016-12-31	CN¥176.26 Million ≈ $25.79 Million	CN¥55.02 Million ≈ $8.05 Million	0.312x	+1.31%
2015-12-31	CN¥114.46 Million ≈ $16.75 Million	CN¥35.27 Million ≈ $5.16 Million	0.308x	-45.45%
2014-12-31	CN¥54.10 Million ≈ $7.92 Million	CN¥30.56 Million ≈ $4.47 Million	0.565x	-71.96%
2013-12-31	CN¥20.46 Million ≈ $2.99 Million	CN¥41.21 Million ≈ $6.03 Million	2.014x	+332.61%
2012-12-31	CN¥7.80 Million ≈ $1.14 Million	CN¥-6.76 Million ≈ $-988.72K	-0.866x	--

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology

Market Cap

$624.76 Million

CN¥4.27 Billion CNY

Market Cap Rank

#11116 Global

#3084 in China

Share Price

CN¥17.07

Change (1 day)

-0.76%

52-Week Range

CN¥15.40 - CN¥41.34

All Time High

CN¥85.44